Orthopedic Business
Q&A: Consortium strives to identify best practices for severe extremity trauma
Military orthopedic surgeons experienced a surge of casualties with complex single or multiple extremity injuries during Operation Iraqi Freedom and Operation Enduring Freedom in Afghanistan.
Q&A: New residency program aims to teach innovative advances in orthopedic surgery
Morristown Medical Center announced it established a comprehensive medical education program comprised of a 5-year orthopedic surgery residency and 1-year fellowship in adult reconstruction, according to a press release.
Enovis announces acquisition of Novastep
Enovis Corporation announced that it has acquired Novastep, a subsidiary of Amplitude Surgical SA and global developer of foot and ankle solutions, according to a company press release.
Where loans can be accessed with interest rates less than 1%
With the rapid rise of interest rates in the last year, many physicians might be interested and surprised to learn where extremely low rates still exist.
AMA reelects orthopedic surgeon Michael Suk, MD, JD, MPH, MBA, to board of trustees
The AMA announced Michael Suk, MD, JD, MPH, MBA, has been reelected to the AMA board of trustees, according to a press release.
Hospital for Special Surgery appoints executive vice president, chief operating officer
Hospital for Special Surgery has announced Mary E. Cassai, MPA, BSN, RN, NEA-BC, as executive vice president and chief operating officer, according to a press release.
Speaker: Surgeons should understand goals, audience before using social media
NEW ORLEANS — Orthopedic surgeons should understand their goals and audience and be consistent in their branding when using social media, according to a presenter here.
VIDEO: Kenneth R. Zaslav, MD, provides update on achievements of the Biologic Association
NEW ORLEANS — In this video, Kenneth R. Zaslav, MD, provides an update on the accomplishments of the Biologic Association from 2022 to 2023.
NuVasive net sales increase 5.8% amid uptick in spine procedures
Net sales at NuVasive Inc increased 5.8% in the first quarter of 2023 compared with the same quarter last year, according to a press release.
Heron Therapeutics sales grew in first quarter, driven by chemotherapy nausea drugs
Net product sales at Heron Therapeutics Inc. grew 26% in the first quarter of 2023 compared with the same quarter last year, driven by 15% growth in its oncology care products, according to a press release on quarterly financial results.